Stock Analysis on Net
Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Beginner level

Intuitive Surgical Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel LibreOffice Calc
Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Accounts payable 1.09 1.08 1.35 1.27 1.45 1.52 1.59 1.28 1.32 1.49 1.50 1.43 1.42 1.41 1.54 1.06 0.98 1.12 1.09 1.07 1.24 1.49 1.65
Accrued compensation and employee benefits 1.65 1.67 1.58 2.58 2.05 1.88 1.52 2.47 2.00 1.87 1.61 2.91 2.21 2.12 1.79 2.10 1.69 1.63 1.46 2.39 1.93 2.00 1.67
Deferred revenue 3.09 3.40 3.41 3.47 3.37 3.60 3.62 3.75 3.84 3.97 3.96 4.94 5.00 5.50 5.68 3.71 3.72 3.95 4.25 4.60 4.81 4.98 5.14
Other accrued liabilities 2.60 3.01 3.22 3.26 3.32 2.47 2.26 2.95 2.46 2.40 1.97 2.94 2.27 2.39 2.60 2.33 2.17 1.76 1.74 1.96 2.25 2.43 2.61
Current liabilities 8.43% 9.15% 9.56% 10.58% 10.19% 9.46% 8.99% 10.46% 9.61% 9.73% 9.04% 12.23% 10.91% 11.42% 11.61% 9.20% 8.55% 8.47% 8.54% 10.02% 10.22% 10.89% 11.07%
Other long-term liabilities 4.11 4.08 4.19 4.30 4.64 5.21 5.52 4.32 4.47 4.58 5.27 5.68 1.22 2.45 2.54 1.74 1.70 1.90 1.94 1.95 1.89 2.01 2.03
Long-term liabilities 4.11% 4.08% 4.19% 4.30% 4.64% 5.21% 5.52% 4.32% 4.47% 4.58% 5.27% 5.68% 1.22% 2.45% 2.54% 1.74% 1.70% 1.90% 1.94% 1.95% 1.89% 2.01% 2.03%
Total liabilities 12.53% 13.23% 13.76% 14.88% 14.83% 14.67% 14.51% 14.77% 14.08% 14.31% 14.31% 17.91% 12.13% 13.87% 14.15% 10.93% 10.25% 10.37% 10.48% 11.98% 12.11% 12.90% 13.11%
Preferred stock, $0.001 par value, issuable in series; no shares issued and outstanding 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, $0.001 par value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 59.38 60.23 59.92 59.15 61.34 63.65 64.71 65.89 69.18 71.96 74.96 81.26 74.24 77.13 80.54 64.93 66.97 68.83 70.47 69.89 71.17 72.29 73.30
Retained earnings 27.66 26.06 25.99 25.63 23.46 21.32 20.60 19.39 16.86 13.84 10.86 1.07 13.76 9.19 5.48 24.28 22.72 20.64 19.03 18.32 16.78 14.96 13.63
Accumulated other comprehensive income (loss) 0.15 0.22 0.09 0.13 0.19 0.19 -0.01 -0.17 -0.23 -0.24 -0.28 -0.27 -0.16 -0.19 -0.17 -0.14 0.06 0.16 0.02 -0.19 -0.06 -0.15 -0.03
Total Intuitive Surgical, Inc. stockholders’ equity 87.19% 86.51% 86.00% 84.90% 85.00% 85.16% 85.30% 85.12% 85.82% 85.56% 85.54% 82.06% 87.83% 86.13% 85.85% 89.07% 89.75% 89.63% 89.52% 88.02% 87.89% 87.10% 86.89%
Noncontrolling interest in joint venture 0.27 0.26 0.24 0.21 0.17 0.17 0.20 0.11 0.11 0.13 0.14 0.03 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total stockholders’ equity 87.47% 86.77% 86.24% 85.12% 85.17% 85.33% 85.49% 85.23% 85.92% 85.69% 85.69% 82.09% 87.87% 86.13% 85.85% 89.07% 89.75% 89.63% 89.52% 88.02% 87.89% 87.10% 86.89%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (filing date: 2020-10-19), 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Intuitive Surgical Inc.’s current liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Intuitive Surgical Inc.’s long-term liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q1 2020 to Q2 2020 but then slightly increased from Q2 2020 to Q3 2020.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Intuitive Surgical Inc.’s total liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Total Intuitive Surgical, Inc. stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Intuitive Surgical Inc.’s total Intuitive Surgical, Inc. stockholders’ equity as a percentage of total liabilities and stockholders’ equity increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.